<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1367D45-734D-4891-9671-3C7C7C31D0A0"><gtr:id>D1367D45-734D-4891-9671-3C7C7C31D0A0</gtr:id><gtr:name>UCB Pharma</gtr:name><gtr:address><gtr:line1>Researchdreef 60</gtr:line1><gtr:line2>Allee de la Recherche 60</gtr:line2><gtr:postCode>B-1070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Biological Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1367D45-734D-4891-9671-3C7C7C31D0A0"><gtr:id>D1367D45-734D-4891-9671-3C7C7C31D0A0</gtr:id><gtr:name>UCB Pharma</gtr:name><gtr:address><gtr:line1>Researchdreef 60</gtr:line1><gtr:line2>Allee de la Recherche 60</gtr:line2><gtr:postCode>B-1070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/89930355-330F-42C6-9521-10EAFB43CAFA"><gtr:id>89930355-330F-42C6-9521-10EAFB43CAFA</gtr:id><gtr:firstName>Richard Michael</gtr:firstName><gtr:surname>Maizels</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501474"><gtr:id>41261264-94E5-4700-905A-6374FE778BF3</gtr:id><gtr:title>The impact of helminth infections on allergies: regulatory interactions and protective mechanisms in airway inflammation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501474</gtr:grantReference><gtr:abstractText>Helminth parasites are worms that can evade the body?s natural defences, exploiting an ?Achilles heel? in our immune system. Certain helminths exploit so-called ?regulatory cells?, whose role is to stop the immune system from attacking the body?s own proteins or from attacking harmless environmental molecules. By expanding the regulatory cells, the parasites not only disable the immune response to themselves, but dampen reactions to other ?bystander? proteins such as allergens from house dust mite. In this project, we propose to test whether this effect provides a long-lasting protection against infection, or is lost on treatment to remove parasites; to analyse the cells and molecules involved in inhibiting allergy in the airways, using an animal model for asthma; and to test whether the presence of the parasite can switch potentially damaging allergen-reactive cells into becoming regulatory cells themselves. As a result of this research, we may be able to develop new therapeutic strategies, borrowed from the parasites, to treat allergies and other immune-related diseases.</gtr:abstractText><gtr:technicalSummary>Recent evidence argues that parasitic helminth infections can protect against Th2-mediated allergic pathologies, even though helminths themselves induce strong Th2 responses. We have shown, in a model system, that alleviation of airway allergy is not achieved through immune deviation to Th1, but is linked to expansion of regulatory T cell (Treg) activity. Treg phenotype cells from an infected, allergen-naive animal can transfer protection against airway inflammation to an uninfected, sensitised mouse. In this project, we will examine the physiological extent and stability of the protective effect, the longevity of Treg activity, and the importance of early-life exposure. We will analyse the requirement of Treg cells for parasite antigens, and their relationship to other subsets with suppressive capacity. We will test the role of candidate suppressive molecules (such as TGF-beta) which may mediate the block on Th2 inflammation. Using adoptive transfer systems, we will examine whether allergen-specific Tregs are induced by infection, or if such cells arise under the influence of a primary population of helminth-specific Treg cells. These data will provide the conceptual and experimental basis for future application of helminth-derived mediators in therapy of allergies and other immunopathologies.</gtr:technicalSummary><gtr:fund><gtr:end>2009-12-10</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-12-11</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>630732</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>UCB Pharma</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCB Celltech</gtr:department><gtr:description>Parasite derived immunomodulators</gtr:description><gtr:id>6F15C52D-FD0E-4F08-921D-4B59BA11412E</gtr:id><gtr:impact>Award of CASE studentship, 2009</gtr:impact><gtr:outcomeId>4FF0302444F-1</gtr:outcomeId><gtr:partnerContribution>Assistance with generation and manipulation of antibodies</gtr:partnerContribution><gtr:piContribution>Fractionation and identification of potential immunomodulators from parasites</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Newspaper articles on the Hygiene Hypothesis</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>813FE9BE-A6DE-49CD-807C-7B05DB2B9950</gtr:id><gtr:impact>Discussions and providing comments for medical reporters from the New York Times

Quoted in New York Times article on 1 July 2008</gtr:impact><gtr:outcomeId>426BD8CF3BB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>468750</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pathways for asthma suppression mediated by helminth parasite products</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>American Asthma Foundation</gtr:fundingOrg><gtr:id>DA4FF06C-3299-4B3F-9A4C-AED3FDAD8E34</gtr:id><gtr:outcomeId>Z3BFXWEVomG0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>468750</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Senior Investigator Award</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>American Asthma Foundation</gtr:fundingOrg><gtr:id>3ECB6F18-1797-46F4-8075-4D833EF39EED</gtr:id><gtr:outcomeId>q8Tre7qMBkN0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Programme Grant (Mediators of regulation and immunity in helminth infections)</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>75EC1C7C-A630-44DE-B23E-0E8DB8587334</gtr:id><gtr:outcomeId>02651C8D4C90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9A59E895-46A1-434D-AEA2-F4B73D4A1B13</gtr:id><gtr:title>The Hygiene Hypothesis and Darwinian Medicine</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69c77193fa1049bcbd0c0c72d3d8787c"><gtr:id>69c77193fa1049bcbd0c0c72d3d8787c</gtr:id><gtr:otherNames>Maizels R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:isbn>978-3-7643-8902-4</gtr:isbn><gtr:outcomeId>4993D64D307</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DB2B374-3A40-411B-B993-4C06FB239C5E</gtr:id><gtr:title>T-cell regulation in helminth parasite infections: implications for inflammatory diseases.</gtr:title><gtr:parentPublicationTitle>Chemical immunology and allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b04ca905b9c5b5e9356cd4408caf4b5"><gtr:id>1b04ca905b9c5b5e9356cd4408caf4b5</gtr:id><gtr:otherNames>Maizels RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0079-6034</gtr:issn><gtr:outcomeId>FF3099C51A1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1207C2A1-47C0-4041-8DAF-ED8A7F4F2A0A</gtr:id><gtr:title>Suppression of type 2 immunity and allergic airway inflammation by secreted products of the helminth Heligmosomoides polygyrus.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18f3d455973d0aabe68ed89b739a95be"><gtr:id>18f3d455973d0aabe68ed89b739a95be</gtr:id><gtr:otherNames>McSorley HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_13533_23_22706967</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26F0D6A9-03F3-4F8B-8CFF-0D8DEEA1BA26</gtr:id><gtr:title>Chitinases and chitinase-like proteins: potential therapeutic targets for the treatment of T-helper type 2 allergies.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51576781d6d6536e047b0f6790fb2e0a"><gtr:id>51576781d6d6536e047b0f6790fb2e0a</gtr:id><gtr:otherNames>Sutherland TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>7BA73EC67E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>348D9280-D263-46BC-9CCD-4966F7EB4418</gtr:id><gtr:title>Exploring the immunology of parasitism--from surface antigens to the hygiene hypothesis.</gtr:title><gtr:parentPublicationTitle>Parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b04ca905b9c5b5e9356cd4408caf4b5"><gtr:id>1b04ca905b9c5b5e9356cd4408caf4b5</gtr:id><gtr:otherNames>Maizels RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0031-1820</gtr:issn><gtr:outcomeId>EFF2BB60583</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501474</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>